Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$473000.0.

  • Bioventus' Cash from Investing Activities fell 63906.25% to -$473000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 133764.43%. This contributed to the annual value of $23.0 million for FY2024, which is 1592.65% down from last year.
  • Bioventus' Cash from Investing Activities amounted to -$473000.0 in Q3 2025, which was down 63906.25% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Cash from Investing Activities ranged from a high of $45.0 million in Q3 2023 and a low of -$221.3 million during Q4 2021
  • For the 5-year period, Bioventus' Cash from Investing Activities averaged around -$18.6 million, with its median value being -$2.0 million (2023).
  • Per our database at Business Quant, Bioventus' Cash from Investing Activities tumbled by 1283267.1% in 2021 and then skyrocketed by 417851.1% in 2024.
  • Quarter analysis of 5 years shows Bioventus' Cash from Investing Activities stood at -$221.3 million in 2021, then soared by 98.46% to -$3.4 million in 2022, then skyrocketed by 82.63% to -$591000.0 in 2023, then surged by 4178.51% to $24.1 million in 2024, then crashed by 101.96% to -$473000.0 in 2025.
  • Its Cash from Investing Activities was -$473000.0 in Q3 2025, compared to -$1.4 million in Q2 2025 and -$826000.0 in Q1 2025.